QRSL1 and hepatocellular carcinoma: The T→C variation of this polymorphism has been predicted to create a GATA-binding site and could affect the transcription factor GATA activity and further affect the mature hsa-mir-34b/c expression [36], which may be the reason for the rs4938723 associated with HCC risk.